NO881936L - PROCEDURE FOR THE PREPARATION OF L-ASCORBIC ACID DERIVATIVES. - Google Patents

PROCEDURE FOR THE PREPARATION OF L-ASCORBIC ACID DERIVATIVES. Download PDF

Info

Publication number
NO881936L
NO881936L NO881936A NO881936A NO881936L NO 881936 L NO881936 L NO 881936L NO 881936 A NO881936 A NO 881936A NO 881936 A NO881936 A NO 881936A NO 881936 L NO881936 L NO 881936L
Authority
NO
Norway
Prior art keywords
ascorbic acid
stated
tertiary amine
acid
protected
Prior art date
Application number
NO881936A
Other languages
Norwegian (no)
Other versions
NO881936D0 (en
Inventor
Horst Pauling
Christof Wehrli
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO881936D0 publication Critical patent/NO881936D0/en
Publication of NO881936L publication Critical patent/NO881936L/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/62Three oxygen atoms, e.g. ascorbic acid
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Catalysts (AREA)

Description

Oppfinnelsen vedrører en fremgangsmåte ved fremstilling av L-askorbinsyrederivater, især L-askorbinsyre-2-sulfat og saltene derav. The invention relates to a method for the production of L-ascorbic acid derivatives, in particular L-ascorbic acid-2-sulphate and its salts.

Fremgangsmåten erkarakterisert vedat man behandler en L-askorbinsyre med beskyttet 5,6-stilling med et salt av et tert. amin med pyrosvovelsyre eller rykende svovelsyre og avspalter derefter beskyttelsesgruppen og overfører eventuelt det erholdte L-askorbinsyre-2-sulfat i et salt. The method is characterized by treating an L-ascorbic acid with a protected 5,6 position with a salt of a tart. amine with pyrosulphuric acid or fuming sulfuric acid and then cleaves off the protecting group and optionally transfers the obtained L-ascorbic acid-2-sulphate in a salt.

På egnet måte fremstiller man saltet av det tertiære amin med pyrosvovelsyre eller rykende svovelsyre in situ, dvs. man omsetter den beskyttede L-askorbinsyre med et alkali-eller jordalkalipyrosulfat i nærvær av det tertiære amin, hhv. at man omsetter den beskyttede L-askorbinsyre med rykende svovelsyre i nærvær av det tertiære amin. Alternativt kan imidlertid saltet fremstilles på forhånd, hensiktsmessig ved tilsetning av rykende svovelsyre til aminet i et oppløsningsmiddel såsom metylenklorid. The salt of the tertiary amine is suitably prepared with pyrosulphuric acid or fuming sulfuric acid in situ, i.e. the protected L-ascorbic acid is reacted with an alkali or alkaline earth pyrosulphate in the presence of the tertiary amine, or that the protected L-ascorbic acid is reacted with fuming sulfuric acid in the presence of the tertiary amine. Alternatively, however, the salt may be prepared in advance, conveniently by adding fuming sulfuric acid to the amine in a solvent such as methylene chloride.

Som beskyttelsesgrupper for 5,6-stillingen av L-askorbinsyren fungerer hensiktsmessig: Ketaler av lavere alifatiske eller cykloalifatiske ketoner som f.eks. av aceton, dietylketon, etylmetylketon eller cykloheksanon, acetaler av aldehyder som f.eks. benzalde-hyd eller propionaldehyd. Suitable protecting groups for the 5,6-position of L-ascorbic acid are: Ketals of lower aliphatic or cycloaliphatic ketones such as e.g. of acetone, diethyl ketone, ethyl methyl ketone or cyclohexanone, acetals of aldehydes such as benzaldehyde or propionaldehyde.

Den foretrukkede L-askorbinsyre med beskyttet 5,6-stilling er 5,6-isopropyliden-L-askorbinsyren. The preferred 5,6-protected L-ascorbic acid is 5,6-isopropylidene-L-ascorbic acid.

Egnede tertiære aminer er tri alkylaminer såsom tri-lavere-alkylaminer, f.eks. trimetyl-, trietyl-, tri-n-propyl- og tri-isopropylamin; eller aromatiske aminer, f.eks. pyridin og picolin. Suitable tertiary amines are tri alkylamines such as tri-lower alkylamines, e.g. trimethyl, triethyl, tri-n-propyl and tri-isopropylamine; or aromatic amines, e.g. pyridine and picoline.

Som alkalisalter av pyrosvovelsyren fungerer de vanlige respektive salter, nemlig litium-, natrium-, kalium- eller sesiumsaltet, som jordalkalimetallsalt magnesium-, kalsium-, strontium- eller bariumsaltet. As alkali salts of the pyrosulphuric acid, the usual respective salts, namely the lithium, sodium, potassium or cesium salt, act as alkaline earth metal salts the magnesium, calcium, strontium or barium salt.

Det frie SO^-innhold i den rykende svovelsyre (oleum) kan variere i et stort område, f.eks. 2-80 vekts%, spesielt ca. 55-70 vekts%. Det trengs 1 mol fritt SO^pr. mol av den beskyttede askorbinsyre. The free SO^ content in the fuming sulfuric acid (oleum) can vary over a large range, e.g. 2-80% by weight, especially approx. 55-70% by weight. 1 mole of free SO^per is needed. moles of the protected ascorbic acid.

Fremgangsmåten ifølge oppfinnelsen gjennomføres hensiktsmessig i et vannfritt aprotisk, basisk oppløsningsmiddel. Egnede slike oppløsningsmidler er f.eks. dimetylformamid, hhv. det ovennevnte tertiære amin. The method according to the invention is conveniently carried out in an anhydrous aprotic, basic solvent. Suitable such solvents are e.g. dimethylformamide, respectively the above tertiary amine.

Det molare forhold av tertiært amin til pyrosvovelsyre hhv. rykende svovelsyre kan variere i et stort område, f.eks. ca. 1-10:1. I en egnet utførelsesform fungerer det tertiære amin som oppløsningsmiddel. The molar ratio of tertiary amine to pyrosulphuric acid or fuming sulfuric acid can vary over a large area, e.g. about. 1-10:1. In a suitable embodiment, the tertiary amine acts as a solvent.

Det arbeides hensiktsmessig ved romtemperatur eller ved lett øket temperatur, dvs. ved temperaturer på ca. 20 - 50°C. It is appropriate to work at room temperature or at a slightly increased temperature, i.e. at temperatures of approx. 20 - 50°C.

Opparbeidelsen av det primære reaksjonsprodukt, dvs. L-askorbinsyre-2-sulfatet med beskyttet 5,6-stilling, omfatter hensiktsmessig følgende trinn: Fjerning av uor-ganiske sulfater, f.eks. ved utfelling med kalsiumhydroksyd, behandling med en sterkt sur ioneutbytter for av-spaltning av beskyttelsesgruppen, og til slutt behandling med en uorganisk base, dvs. et alkalimetall- eller jord-alkalimetallhydroksyd for fremstilling av alkalimetall-hhv. jordalkalisulfatet som er av spesiell interesse. The processing of the primary reaction product, i.e. the L-ascorbic acid 2-sulphate with a protected 5,6-position, suitably comprises the following steps: Removal of inorganic sulphates, e.g. by precipitation with calcium hydroxide, treatment with a strongly acidic ion exchanger to remove the protective group, and finally treatment with an inorganic base, i.e. an alkali metal or alkaline earth metal hydroxide to produce alkali metal or the alkaline earth sulfate which is of particular interest.

Fra US-patent nr. 3 954 809 er det kjent en fremgangsmåte til sulfatering av L-askorbinsyre til det tilsvarende 2-sulfat under anvendelse av et preformert amin-svovel trioksyd-kompleks som sulfateringsmiddel.Imidlertid er fremstillingen av dette amin-svoveltrioksyd-kompleks be-lastet med temmelig store ubehageligheter, fordi man tvangsmessig må arbeide med fritt SO^. Disse ubehageligheter bortfaller i det foreliggende tilfellet: Idet oleum i svovelsyre-fremstillingen dannes i lukket kretsløp, kreves det ved fremstillingen av amin-svoveltrioksyd-komplekset sikkerhetsforanstaltninger over gjennomsnittet ved håndteringen av fritt svoveltrioksyd. From US patent no. 3,954,809, a method is known for sulphating L-ascorbic acid to the corresponding 2-sulphate using a preformed amine-sulfur trioxide complex as a sulphating agent. However, the production of this amine-sulfur trioxide complex is burdened with rather great unpleasantness, because one has to compulsorily work with free SO^. These inconveniences disappear in the present case: As oleum in the sulfuric acid production is formed in a closed circuit, above-average safety measures are required in the production of the amine-sulphur trioxide complex when handling free sulfur trioxide.

Fremgangsmåten ifølge oppfinnelsen skal forklares nærmere ved hjelp av de følgende eksempler: The method according to the invention shall be explained in more detail by means of the following examples:

EKSEMPEL 1EXAMPLE 1

I en 3 1 firehalset rundkolbe med rører, termometer og inertbegassing anbringes 216 g (1,00 mol) 216 g (1.00 mol) are placed in a 3 1 four-neck round-bottomed flask with stirrer, thermometer and inert gas

5,6-isopropyliden-L-askorbinsyre, 600 ml pyridin, 356 g (1,40 mol) kaliumdisulfat (kaliumpyrosulfat ) , 400 ml glasskuler (ø3 mm) og røres i 16 timer ved romtemperatur. Glasskulene separeres og eftervaskes med 500 ml vann. Suspensjonen avfiltreres. Filtratet oppvarmes i en 3 1 sulfoneringskolbe med rører og termometer til 50°C. Til dette tilsettes en suspensjon av 104 g kalisumhydroksyd (96% =1,4 mol) i 500 ml vann. Efter 1 times omrøring ved romtemperatur avfiltreres det utfelte kalsiumsulfat og eftervaskes med 2 x 250 ml vann. Filtratet inndampes i en rotavapor i vannstrålevakuum til ca. 700 ml. Produktopp-løsningen filtreres gjennom en ioneutbytter, nemlig 1,5 kg Dowex 50W X8 16-40 mesh. Ioneutbytteren eftervaskes med 1,6 1 vann. Eluatet fanges opp og henstår ved romtemperatur inntil fullstendig hydrolyse av isopropyliden-beskyttelsesgruppen. Oppløsningen innstilles med 184 ml 10N kalium-hydroksyd til pH 8,0 + 0,5 og inndampes i rotavaporen i vannstrålevakuum til ca. 750 ml. I en 2 1 rundkolbe tilsettes til denne oppløsning dråpevis under omrøring 850 ml metanol. Det utfelte produkt avfiltreres og filtratkaken 5,6-isopropylidene-L-ascorbic acid, 600 ml pyridine, 356 g (1.40 mol) potassium disulfate (potassium pyrosulfate), 400 ml glass balls (ø3 mm) and stirred for 16 hours at room temperature. The glass beads are separated and washed with 500 ml of water. The suspension is filtered off. The filtrate is heated in a 3 1 sulphonation flask with stirrer and thermometer to 50°C. To this is added a suspension of 104 g of potassium hydroxide (96% = 1.4 mol) in 500 ml of water. After stirring for 1 hour at room temperature, the precipitated calcium sulphate is filtered off and washed with 2 x 250 ml water. The filtrate is evaporated in a rotavapor in a water jet vacuum to approx. 700 ml. The product solution is filtered through an ion exchanger, namely 1.5 kg Dowex 50W X8 16-40 mesh. The ion exchanger is then washed with 1.6 1 water. The eluate is collected and left at room temperature until complete hydrolysis of the isopropylidene protecting group. The solution is adjusted with 184 ml of 10N potassium hydroxide to pH 8.0 + 0.5 and evaporated in the rotavapor in a water jet vacuum to approx. 750 ml. In a 2 1 round-bottomed flask, 850 ml of methanol are added dropwise to this solution while stirring. The precipitated product is filtered off and the filtrate cake

eftervaskes med en blanding, av 400 ml metanol/vann (55:45 G/G). Filtratkaken tørkes i vannstrålevakuum. Man oppnår: 273,7 g dikalium-L-askorbat-2-sulfat . 2 H^O, innhold: washed with a mixture of 400 ml methanol/water (55:45 G/G). The filtrate cake is dried in a water jet vacuum. One obtains: 273.7 g of dipotassium L-ascorbate-2-sulphate. 2 H^O, content:

96% (ifølge HPLC).96% (according to HPLC).

EKSEMPEL 2EXAMPLE 2

I en 3 1 firehalset rundkolbe med rører og termometer anbringes under nitrogenatmosfaere 216 g (1,00 mol) 5,6-isopropylidenaskorbinsyre, 600 ml pyridin og 280 g (= 1,10 mol fritt SO^) pyridinpolysulfat og røres i 18 timer ved romtemperatur. ["Pyridinpolysulfatet" fremstilles ved tilsetning av 100 ml rykende svovelsyre (oleum 60%) til 240 ml pyridin (Py) ill metylenklorid. Det resulterende "pyridinpolysulfat" (378,4 g) har sammensetningen<Py>2<H>2S2°7"0,84<p>yS03^-Til den nesten 216 g (1.00 mol) of 5,6-isopropylidene ascorbic acid, 600 ml of pyridine and 280 g (= 1.10 mol of free SO^) of pyridine polysulphate are placed under a nitrogen atmosphere in a 3 l four-necked round flask with stirrer and thermometer and stirred for 18 hours at room temperature. [The "pyridine polysulphate" is prepared by adding 100 ml of fuming sulfuric acid (oleum 60%) to 240 ml of pyridine (Py) in methylene chloride. The resulting "pyridine polysulfate" (378.4 g) has the composition<Py>2<H>2S2°7"0.84<p>yS03^-To the almost

fullstendig oppløste blanding tilsettes 600 ml vann. Oppløsningen oppvarmes til 50°C. Til dette tilsettes en suspensjon av 136 g (96 % = 1,84 mol) kalsiumhydroksyd og 500 ml vann i løpet av 30 minutter. Suspensjonen røres i 1 time ved romtemperatur og det utfelte kalsiumsulfat avfiltreres og utpresses kraftig. Filtratkaken løses i 200 ml vann og eftervaskes. Filtratet inndampes på vannstrålevakuum til ca. 500 ml. Suspensjonen avfiltreres og resten eftervaskes med 300 ml vann. Filtratet filtreres gjennom en sterkt sur ioneutbytter, dvs. 1,58 kg Dowex 50 W X8. Det eftervaskes med 1,6 1 vann og eluatet fanges opp og henstår ved romtemperatur inntil isopropylidenbeskyttelsesgruppens fullstendige hydrolyse. Den sterkt sure oppløsning completely dissolved mixture is added to 600 ml of water. The solution is heated to 50°C. To this is added a suspension of 136 g (96% = 1.84 mol) of calcium hydroxide and 500 ml of water over the course of 30 minutes. The suspension is stirred for 1 hour at room temperature and the precipitated calcium sulphate is filtered off and squeezed out vigorously. The filtrate cake is dissolved in 200 ml of water and then washed. The filtrate is evaporated on a water jet vacuum to approx. 500 ml. The suspension is filtered off and the residue is washed with 300 ml of water. The filtrate is filtered through a strongly acidic ion exchanger, i.e. 1.58 kg Dowex 50 W X8. It is then washed with 1.6 1 water and the eluate is collected and left at room temperature until the complete hydrolysis of the isopropylidene protecting group. The strongly acidic solution

innstilles med 214 ml 10N KOH til pH 8,0 + 0,5 og inndampes i vannstrålevakuum til ca. 750 ml. Til produktoppløsningen tilsettes dråpevis under omrøring i en 2 1 rundkolbe 850 ml metanol. Det utfelte produkt avfiltreres og filtratkaken adjusted with 214 ml 10N KOH to pH 8.0 + 0.5 and evaporated in a water jet vacuum to approx. 750 ml. 850 ml methanol is added dropwise to the product solution while stirring in a 2 l round bottom flask. The precipitated product is filtered off and the filtrate cake

eftervaskes med en blanding av 400 ml metanol/vann 55:45 G/G. Produktet tørkes i 18 timer i vannstrålevakuum ved 45°C. Man oppnår 290,5 g dikaliumaskorbat-2-sulfat . 2 H20, innhold 92 %. washed with a mixture of 400 ml methanol/water 55:45 G/G. The product is dried for 18 hours in a water jet vacuum at 45°C. 290.5 g of dipotassium ascorbate-2-sulphate is obtained. 2 H20, content 92%.

Claims (10)

1. Fremgangsmåte ved fremstilling av L-askorbinsyre-2-sulfat og salter derav, karakterisert ved at man behandler en L-askorbinsyre med beskyttet 5,6-stilling med et salt av et tertiært amin med pyrosvovelsyre eller rykende svovelsyre og derefter avspalter beskyttelsesgruppen og eventuelt overfører det erholdte L-askorbinsyre-2-sulfat i et salt.1. Process for the production of L-ascorbic acid 2-sulphate and salts thereof, characterized by treating an L-ascorbic acid with a protected 5,6-position with a salt of a tertiary amine with pyrosulphuric acid or fuming sulfuric acid and then cleaving off the protective group and optionally transfers the obtained L-ascorbic acid-2-sulfate in a salt. 2. Fremgangsmåte som angitt i krav 1, karakterisert ved at man omsetter den beskyttede L-askorbinsyre med et alkali- eller jordalkalipyrosulfat i nærvær av det tertiære amin.2. Method as stated in claim 1, characterized in that the protected L-ascorbic acid is reacted with an alkali or alkaline earth pyrosulfate in the presence of the tertiary amine. 3. Fremgangsmåte som angitt i krav 1, karakterisert ved at man omsetter den beskyttede L-askorbinsyre med rykende svovelsyre i nærvær av det tertiære amin.3. Method as stated in claim 1, characterized in that the protected L-ascorbic acid is reacted with fuming sulfuric acid in the presence of the tertiary amine. 4. Fremgangsmåte som angitt i ett av kravene 1 til 3, karakterisert ved at et acetal eller ketal fungerer som beskyttelsesgruppe.4. Method as stated in one of claims 1 to 3, characterized in that an acetal or ketal functions as a protecting group. 5. Fremgangsmåte som angitt i krav 4, karakterisert ved at man anvender 5,6-isopropyliden-L-askorbinsyre som utgangsmateriale.5. Method as stated in claim 4, characterized in that 5,6-isopropylidene-L-ascorbic acid is used as starting material. 6. Fremgangsmåte som angitt i ett av kravene 1 til 5, karakterisert ved at et trialkylamin eller pyridin benyttes som tertiært amin.6. Method as stated in one of claims 1 to 5, characterized in that a trialkylamine or pyridine is used as tertiary amine. 7. Fremgangsmåte som angitt i ett av kravene 1 til 6, karakterisert ved at man behandler L-askorbinsyren med et alkalipyrosulfat, især med K2 S2 0? .7. Method as stated in one of claims 1 to 6, characterized in that the L-ascorbic acid is treated with an alkali pyrosulphate, in particular with K2 S2 0? . 8. Fremgangsmåte som angitt i ett av kravene 1 til 7, karakterisert ved at den rykende svovelsyre inneholder ca. 2-80 vekts%, især ca. 55-70 vekts% fritt SO^ .8. Method as stated in one of claims 1 to 7, characterized in that the fuming sulfuric acid contains approx. 2-80% by weight, especially approx. 55-70% by weight free SO^ . 9. Fremgangsmåte som angitt i ett av kravene 1 til 8, karakterisert ved at man arbeider i et vannfritt, aprotisk basisk oppløsningsmiddel.9. Method as stated in one of claims 1 to 8, characterized in that one works in an anhydrous, aprotic basic solvent. 10. Fremgangsmåte som angitt i ett av kravene 1 til 8, karakterisert ved at det som oppløsnings-middel anvendes det tertiære amin.10. Method as stated in one of claims 1 to 8, characterized in that the tertiary amine is used as solvent.
NO881936A 1987-05-04 1988-05-03 PROCEDURE FOR THE PREPARATION OF L-ASCORBIC ACID DERIVATIVES. NO881936L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH167687 1987-05-04

Publications (2)

Publication Number Publication Date
NO881936D0 NO881936D0 (en) 1988-05-03
NO881936L true NO881936L (en) 1988-11-07

Family

ID=4215991

Family Applications (1)

Application Number Title Priority Date Filing Date
NO881936A NO881936L (en) 1987-05-04 1988-05-03 PROCEDURE FOR THE PREPARATION OF L-ASCORBIC ACID DERIVATIVES.

Country Status (6)

Country Link
EP (1) EP0289894A1 (en)
JP (1) JPS63297375A (en)
KR (1) KR880013913A (en)
CN (1) CN88102718A (en)
DK (1) DK227188A (en)
NO (1) NO881936L (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991013068A1 (en) * 1990-03-01 1991-09-05 Enco Engineering Chur Ag Process for the production of dipostassium ascorbate-2-sulphate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US278831A (en) * 1883-06-05 Car-signal
US3954809A (en) * 1973-01-22 1976-05-04 Kansas State University Research Foundation Preparation of l-ascorbate 2-sulfate from l-ascorbic acid
US4071534A (en) * 1973-11-07 1978-01-31 Kumiai Chemical Industry Co., Ltd. Process for producing l-ascorbic acid-2-sulfate

Also Published As

Publication number Publication date
CN88102718A (en) 1988-11-16
DK227188A (en) 1988-11-05
NO881936D0 (en) 1988-05-03
JPS63297375A (en) 1988-12-05
DK227188D0 (en) 1988-04-26
KR880013913A (en) 1988-12-22
EP0289894A1 (en) 1988-11-09

Similar Documents

Publication Publication Date Title
NO161179B (en) STORAGE MATERIAL FOR STORING THERMAL ENERGY AND PROCEDURE FOR MANUFACTURING THE MATERIAL.
JPH0120145B2 (en)
JPS5988466A (en) Manufacture of 5-methylpyridine
AU2011236155A1 (en) Nitrogen-containing heterocyclic compound and method for producing same
STAHMANN et al. Chemical reactions of mustard gas and related compounds. 1 VII. The chemistry of bis (β-chloroethyl)-sulfone, divinyl sulfone and divinyl sulfoxide
NO881936L (en) PROCEDURE FOR THE PREPARATION OF L-ASCORBIC ACID DERIVATIVES.
EP0156645B1 (en) Process for the preparation of n1-methyl-10alpha-methoxylumilysergol and esters thereof, and intermediates for their preparation
US3971799A (en) Preparation of 3,5,6-trichloropicolinic acid
DK167976B1 (en) METHOD OF PREPARING 6-METHYL-3,4-DIHYDRO-1,2,3-OXATHIAZIN-4-ON-2,2-DIOXIDE OR ITS NON-TOXIC SALTS
RU1779243C (en) Process for producing 3-fluoro-4-aminophenol
JPS6072895A (en) Production of ketal of 2-ketogulonic acid and its ester
JP3926943B2 (en) Method for producing substituted pyridine
Reddy et al. THE REACTION OF PYRIDINE N-OXIDE AND ITS BENZOANALOGUES WITH ARENESULFONYL AZIDES: NOVEL SYNTHESIS OF TETRAZOLOAZlNES
JP4903347B2 (en) Chemical extraction method of 2-hydroxypyridine derivative, 2-hydroxyquinoline and 2-hydroxybenzothiazole
SU595308A1 (en) Method of preparing pyridine 2-chlor-3-sulfochloride
JPS5822476B2 (en) Styrene sulfone styrene sulfone
JPS58121295A (en) Method for converting phosphine sulfide to oxide
JPH0316342B2 (en)
JP3998074B2 (en) Method for demethylation of podophyllotoxin
AU2014201037B9 (en) Nitrogen-containing heterocyclic compound and method for producing same
SU470114A3 (en) Method for producing nucleoside monophosphate
SU527426A1 (en) Method for producing 4,5-dibromimidazole
JPS6023394A (en) Novel uridine derivative
JPH11124385A (en) Water-soluble substituted pyridine-borane
IE44633B1 (en) Process for preparing n-chlorophthalimide